<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03399838</url>
  </required_header>
  <id_info>
    <org_study_id>PedINDEX study</org_study_id>
    <nct_id>NCT03399838</nct_id>
  </id_info>
  <brief_title>Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department</brief_title>
  <acronym>PedINDEX</acronym>
  <official_title>The PedINDex Study: Comparing Intranasal Dexmedetomidine With Oral or Rectal Midazolam for Procedural Sedation in the Pediatric Emergency Department.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anxiety in children needs to be addressed to reduce stress, to be able to perform procedures
      where a child needs to lie still, and to prevent anxiety in the future. Intranasal
      dexmedetomidine has proven to be a very reliable and safe medication in a variety of
      pediatric settings. But, data for the use of dex at the PED are sparse.

      The investigators intend to determine if dexmedetomidine is clinically superior to midazolam
      (standard of care), defined by 20% superiority in anxiety relief, and non-inferiority in
      satisfaction of sedation providers as well as patients and parents. Additional data will be
      collected. Patients aged 6 months and older will be included when midazolam sedation is be
      intended, with main focus on the age group up of those up to 6 years (140 patients in this
      age group). Random assignment will compare dexmedetomidine with midazolam.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2018</start_date>
  <completion_date type="Anticipated">May 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomised trial comparing 2 drugs (midazolam, dexmedetomidine)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety</measure>
    <time_frame>3hour</time_frame>
    <description>Measured with modified Yale preoperative anxiety scale (mYPAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>72hours</time_frame>
    <description>Surveys addressed to all concerned parties (patient, parent, health care professional)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Procedural Anxiety</condition>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of single dose of 4mcg/kg dexmedetomidine intranasally for pediatric procedural sedation at the emergency department</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.5mg po/pr midazolam for pediatric sedation at the emergency department</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>IN Dex for pediatric procedural sedation at the emergency department</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>po/pr midazolam as active comparator to dexmedetomidine for pediatric procedural sedation at the pediatric emergency department</description>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged between 6 months and 25 years presenting at the pediatric emergency
             department

          -  Indication for midazolam as sedation

          -  Signed informed consent

        Exclusion Criteria:

          -  Contraindication for midazolam

          -  Contraindication for dexmedetomidine

          -  Contraindication for moderate sedation in general
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia Hoeffe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Inselspital, Berne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Hoeffe, MD</last_name>
    <phone>0316328707</phone>
    <email>julia.hoeffe@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric Emergency Department, Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Hoeffe</last_name>
      <phone>0041316328707</phone>
      <email>julia.hoeffe@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Roland Ammann</last_name>
      <phone>0316321087</phone>
      <email>roland.ammann@insel.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2018</study_first_submitted>
  <study_first_submitted_qc>January 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2018</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Procedural Sedation and Analgesia</keyword>
  <keyword>Pediatric Emergency Department</keyword>
  <keyword>intranasal</keyword>
  <keyword>dexmedetomidine</keyword>
  <keyword>midazolam</keyword>
  <keyword>anxiety relief</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

